Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma.
Glasheen MQ, Caksa S, Young AG, Wilski NA, Ott CA, Chervoneva I, Flaherty KT, Herlyn M, Xu X, Aplin AE, Capparelli C.
Glasheen MQ, et al. Among authors: chervoneva i.
Mol Cancer Ther. 2023 Sep 5;22(9):1087-1099. doi: 10.1158/1535-7163.MCT-23-0025.
Mol Cancer Ther. 2023.
PMID: 37343247
Free PMC article.